.jpg)
Berlin / Hamburg, October 20, 2025 – YPOG advised lead investor Venrock Healthcare Capital Partners on the successful Series C financing round of Martinsried-based biotech company Tubulis. The round amounts to 308 million EUR (361 million USD) and is one of the largest private financing rounds for a European biotech company this year.
Legal advice was provided in close cooperation with the US law firm Cooley, led by James Schneider, partner in the Boston office.
In addition to Venrock Healthcare Capital Partners, other notable new investors such as Wellington Management and Ascenta Capital participated. Existing investors such as Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, HTGF, OCCIDENT, and Seventure Partners also supported the round.
Tubulis is developing a pipeline of novel, indication-specific antibody-drug conjugates (ADCs) that can be used in a particularly targeted and tolerable manner thanks to a combination of proprietary platform technologies and biological expertise. The new funding will primarily be used to accelerate the clinical development of the lead ADC candidate TUB-040 (for ovarian and lung cancer). TUB-040 is currently in a Phase I/IIa study and was granted Fast Track designation by the US FDA in June 2024. In addition, the financing will be used to expand Tubulis' pipeline, including the clinical ADC candidate TUB-030 (for advanced solid tumors) and several preclinical programs. The company also plans to expand its technology platforms and establish a US subsidiary.
“Tubulis' financing round is a strong signal of the innovative strength of the European biotech ecosystem,” says Dr. Benjamin Ullrich, Co-Managing Partner at YPOG. "With the support of leading international investors such as Venrock Healthcare Capital Partners, a company is being strengthened that has the potential to significantly change cancer therapy with its novel ADC technologies. For YPOG, this is another example of our growing role at the intersection of life sciences, deeptech, and venture capital."
About Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners (VHCP) is a healthcare-focused, late-stage venture capital fund family that invests primarily in publicly-held and late-stage private companies within the healthcare and life sciences industries, with a strong emphasis on small-cap public companies and biotechnology. VHCP focuses on companies developing and commercializing innovative products and technologies. For more information, please visit
Team
Dr. Benjamin Ullrich (Lead, Transactions), Partner, Berlin
Stefan Richter (Tax), Partner, Hamburg
Dr. Benedikt Flöter (IP/IT/Data Protection), Partner, Berlin
Dr. Carolin Raspé (Corporate Crime + Compliance + Investigations), Partner, Munich
Dr. Emma Peters (Transactions), Associated Partner, Berlin
Tobias Lovett (Transactions), Associated Partner, Berlin
Pia Meven (Transactions), Associated Partner, Berlin
Anna Eickmeier (IP/IT/Data Protection), Senior Associate, Berlin
Theresia M.R. Heinrich (Transactions), Senior Associate, Berlin
Konstantina Nathanail (IP/IT/Data Protection), Associate, Berlin
Silke Ricken (Corporate), Associate, Berlin
Dr. Christian Busmann (Tax), Associate, Hamburg
Kontakt
About us
YPOG stands for You + Partners of Gamechangers – forward-thinking legal and tax advice. Supporting companies that are focused on emerging technologies, YPOG embraces change as an opportunity to develop cutting-edge solutions. The YPOG team offers comprehensive expertise in the areas of Funds, Tax, Transactions, Corporate, Banking, Regulatory + Finance, IP/IT/Data Protection, Litigation, and Corporate Crime + Compliance + Investigations. YPOG is one of the leading law firms in Germany for venture capital, private equity, fund structuring, and the implementation of distributed ledger technology (DLT) in financial services. Both the firm and its partners are regularly recognized by renowned national and international publications such as JUVE, Best Lawyers, Chambers and Partners, Leaders League, and Legal 500. YPOG is home to more than 180 experienced attorneys, tax advisors and tax specialists as well as a notary, working across offices in Berlin, Cologne, Hamburg, Munich, Cambridge and London.
Further information: www.ypog.law/en/ and www.linkedin.com/company/ypog